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Does Prophylactic Administration of TXA Reduce Mean Operative Time and Postoperative Blood Loss 
in Posterior Approach Lumbar Spinal Fusion Surgery Performed for Degenerative Spinal Disease?
Evan Larson, Emmett Gannon, Tyler Evans, Jake Long, Elizabeth Lyden, Chris Cornett
Mentor: Chris Cornett
Program: Orthopaedic Surgery
Objective: To investigate association between 
prophylactic TXA administration prior to 
one and two-level posterior lumbar interbody 
fusion operations and perioperative blood 
loss, mean operative time, postoperative 
transfusion, and postoperative venous 
thromboembolic events.
Summary of Background Data: Tranexamic 
acid (TXA) is a systemic anti-fibrinolytic that 
competitively inhibits lysine binding sites on 
plasminogen, reversibly blocking its binding 
to fibrin and impeding fibrinolysis and clot 
degradation. TXA’s role in routine spinal 
surgery remains poorly described. Most spinal 
literature on perioperative TXA administration 
has considered operations performed for 
major adult and pediatric spinal deformity. 
Methods: Two groups, a study group 
composed of 75 patients who underwent one 
and two-level posterior lumbar interbody 
fusion operations for degenerative indications 
who received TXA prior to the start of the 
procedure, and a control group composed of 
75 patients who underwent similar surgeries 
for the same indications and did not receive 
TXA preoperatively, were retrospectively 
enrolled. Demographic, laboratory, and 
surgical data were collected and analyzed.
Results: Statistically significant reductions 
were noted in the TXA group in postoperative 
day 1 drain output (p < 0.0041), total 
postoperative drain output (p = 0.027), and 
mean surgical time (p < 0.0001).
Conclusions: Based on the results of the 
current study, we feel TXA’s routine use 
should be considered in one and two- level 
posterior lumbar fusion operations performed 
for degenerative indications, as it is safe to 
administer routinely and associated with 
reduced postoperative drain output and mean 
surgical time. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.036
Identifying Current Opioid Prescription Practice and Implementing Guidelines after Hand and Upper 
Extremity Surgery – A Project in Quality Improvement
Ryan E Miller, David Brown, Mark Amirtharaj, Brandon Bennett, Todd Gilbert, CJ Hansen, Evan Larson, 
Kent Rinehart, Daniel Firestone, Joseph Morgan, Philipp Streubel, Matthew Teusink
Mentor: Daniel Firestone
Program: Orthopaedic Surgery
Background & Objectives: Opioid pain 
medications prescriptions following upper 
extremity surgery is part of the standard of 
care. However, there is a growing concern 
about opioid abuse, overdose deaths, and 
diversion of opioids in the community. New 
evidence suggesting opioid overprescription 
has prompted a closer look at current practice. 
Objectives of this quality improvement 
project are 1) to define prescribing habits and 
patient utilization of opioids following upper 
extremity surgery within our institution, 2) 
to develop prescription guidelines, and 3) 
to educate patients about opioid usage and 
disposal. 
Methods: Stage I consists of collecting 
prospective data from patients undergoing 
upper extremity surgery by 4 upper extremity 
surgeons over 6 consecutive months. Data 
are gathered from the electronic medical 
record and survey at clinic visits up to 90 
days postoperatively including level of pain, 
opioid pills prescribed (converted to morphine 
equivalents), number of unused pills, and date 
of last opioid use. Patients are asked whether 
they were educated on pill disposal. Results 
will be used to develop prescription guidelines 
and patient education protocols.
Stage II consists of collecting prospective data 
from patients undergoing upper extremity 
surgery by 4 upper extremity surgeons over 
6 consecutive months. Postoperative opioid 
prescriptions guided by previous results will 
be provided with standardized education on 
opioid disposal. The aforementioned data will 
again be collected at clinic visits up to 90 days 
postoperatively. Data from each stage will 
then be compared to assess the effectiveness 
of the implemented guidelines. 
Results & Conclusions: Pending further data 
collection. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.037
Identifying Current Opioid Prescription Practice and Implementing Guidelines after Total Knee 
and Total Hip Arthroplasty
Gordon Roedel, Phillip Thomas, Curtis Hartman, Kevin Garvin, Beau Konigsberg
Mentor: Curtis Hartman
Program: Orthopaedic Surgery
Background & Objectives: Opioid pain 
medications prescribed following total hip 
arthroplasty (THA) and total knee arthroplasty 
(TKA) are critical to postoperative pain 
management. However, a lack of evidence 
regarding appropriate prescription practices 
can contribute to overprescribing and 
diversion of opioids within the community. 
Objectives of this quality improvement project 
are 1) to understand prescribing habits and 
patient utilization of opioids following THA 
47 
and TKA within our institution, 2) develop 
appropriate prescription guidelines, and 3) 
improve patient knowledge regarding unused 
opioid disposal.
Methods: Stage I consists of collecting 
prospective data from opioid-naïve patients 
undergoing primary THA and TKA over 6 
consecutive months. Data are gathered from 
the electronic medical record and survey at 
clinic visits up to 90 days postoperatively 
including level of pain, number/type of opioid 
pills prescribed postoperatively (converted 
to morphine equivalents), number of unused 
pills, and date of last opioid use. Patients are 
asked whether they were educated on disposal 
of unused opioids. Results will be used to 
develop opioid prescription guidelines and 
patient education protocols which will be 
implemented during Stage II. 
Stage II consists of collecting prospective 
data from opioid-naïve patients undergoing 
primary THA and TKA over 6 consecutive 
months. Postoperative opioid prescriptions 
guided by previous results will be provided 
with standardized education on opioid 
disposal. The aforementioned data will again 
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